Stenhouse Mark
SEC insider (Form 3/4/5 filer). CIK 0001734751. Director at Phathom Pharmaceuticals, Inc. (PHAT). 2 reported Form 4/5 transactions since Sep 2024; latest on May 19, 2026. Located in FLORHAM PAK, NJ.
Companies Stenhouse Mark has filed insider reports for
- Phathom Pharmaceuticals, Inc. (PHAT): Director
Stenhouse Mark
CIK: 0001734751
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PHAT
Phathom Pharmaceuticals, Inc.
Director